Search results
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 2 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
Why many lung cancer patients who have never smoked have worse outcomes
Science Daily· 2 days agoThe study, published in Nature Communications, shows that lung cancer cells with two particular genetic mutations are more likely to double their genome, which helps them ...
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Motley Fool via Yahoo Finance· 3 hours agoIts portfolio of new brands includes Zepbound for weight loss, Mounjaro for obesity, cancer medicine...
NHS genomics testing will be vital in supporting personalised cancer trials
Clinical Trials Arena via Yahoo Finance· 1 day agoPeter Johnson, national clinical director for cancer of NHS England said that the genomic medicine...
New cancer treatment increases efficacy by injecting chemo directly into tumor cells
BGR· 6 days agoChemotherapy has proven to be a fairly successful treatment for cancer. The Food and Drug...
Colon Cancer: Immunotherapy Before Surgery May lead to Better Outcomes
Healthline· 7 days agoA pair of immunotherapy drugs have shown impressive results in treating a subset of colorectal ...
Virtua Health offers innovative lung cancer-fighting drug
NJBIZ· 5 days agoMarlton-headquartered Virtua Health is the first South Jersey provider to offer a groundbreaking ...
More men 'should be told about blood test that can detect prostate cancer'
Daily Express· 4 days agoOutdated NHS guidance is “putting lives at risk” by preventing GPs from raising the option of a...
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 3 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...